Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1209713
Max Phase: Preclinical
Molecular Formula: C9H18ClNO
Molecular Weight: 156.25
Molecule Type: Small molecule
Associated Items:
ID: ALA1209713
Max Phase: Preclinical
Molecular Formula: C9H18ClNO
Molecular Weight: 156.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OCC[N+]12CCC(CC1)CC2.[Cl-]
Standard InChI: InChI=1S/C9H18NO.ClH/c11-8-7-10-4-1-9(2-5-10)3-6-10;/h9,11H,1-8H2;1H/q+1;/p-1
Standard InChI Key: HAFVNOXFMKMPMD-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 156.25 | Molecular Weight (Monoisotopic): 156.1383 | AlogP: 0.61 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.97 | CX Basic pKa: | CX LogP: -4.00 | CX LogD: -4.00 |
Aromatic Rings: 0 | Heavy Atoms: 11 | QED Weighted: 0.58 | Np Likeness Score: 0.65 |
1. Geldenhuys WJ, Allen DD, Lockman PR.. (2010) 3-D-QSAR and docking studies on the neuronal choline transporter., 20 (16): [PMID:20637607] [10.1016/j.bmcl.2010.06.090] |
Source(1):